NOREPINEPHRINE BITARTRATE- norepinephrine bitartrate injection, solution 
Cantrell Drug Company

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Norepinephrine Bitartrate 16 mg Added to 5% Dextrose 250 mL Bag

Preparation LabelEnter section text here

NOREPINEPHRINE BITARTRATE 
norepinephrine bitartrate injection, solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUG LABELItem Code (Source)NDC:52533-164
Route of AdministrationINTRAVENOUSDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NOREPINEPHRINE BITARTRATE (NOREPINEPHRINE) NOREPINEPHRINE64 ug  in 1 mL
Inactive Ingredients
Ingredient NameStrength
DEXTROSE50 mg  in 1 mL
SODIUM CHLORIDE473.6 ug  in 1 mL
SODIUM METABISULFITE128 ug  in 1 mL
WATER 
Other Ingredients
Ingredient KindIngredient NameQuantity
May containHYDROCHLORIC ACID 
May containSODIUM HYDROXIDE 
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:52533-164-38250 mL in 1 BAG
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other06/22/201203/12/2015
Labeler - Cantrell Drug Company (035545763)

Revised: 3/2015
Document Id: aab4b766-80a0-46ad-bf6f-43460d5b5837
Set id: 31dcd090-2f1b-405a-9c2e-04fc535ccf4d
Version: 6
Effective Time: 20150312
 
Cantrell Drug Company